Purpose Vascular endothelial growth factor A VEGF A and vascular endothelial growth factor receptor 2 VEGFR2 are often coexpressed in breast cancer, and potentially affect cellular pathways and key proteins such as the estrogen receptor ER targeted by endocrine treatment
stromectol vidal
